Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
Asthma, COPD Medication Adherence Up During Pandemic
Authors say increased adherence may reflect patient concern about controlling primary respiratory illness
CDC: Prevalence of Hypertension Higher in Rural Versus Urban Areas
HTN prevalence varied from 18.0 to 55.0 percent across counties; med use also higher in rural areas
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
RHB-105 Effective for Eradication of Helicobacter pylori in Adults
Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
UGN-101 Active in Chemoablation of Upper Tract Urothelial Cancer
Fifty-nine percent of patients had complete response at four to six weeks after initial therapy
Cardio-Obstetrics Team Key to Managing CVD in Pregnancy
Cardio-obstetrics team should review maternal cardiovascular risk, obstetric risk, fetal risk, outcomes
Organic Nitrates May Not Aid Bone Health in Postmenopausal Women
Additionally, organic nitrates are poorly tolerated with headaches as the major complaint
